Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Haematologica
|
November 1, 1993
Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases
C Schiavotto, F Rodeghiero
Haematologica
|
November 1, 1993
Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature
C Schiavotto, M Ruggeri, F Rodeghiero
Haematologica
|
November 1, 1993
Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol
C Schiavotto, G Castaman, F Rodeghiero
Annals of Hematology
|
February 1, 1995
Failure of repeated courses of high-dose intravenous immunoglobulin to induce stable remission in patients with chronic idiopathic thrombocytopenic purpura
C Schiavotto, M Ruggeri, F Rodeghiero
British Journal of Haematology
|
May 1, 1996
High-dose dexamethasone in adult refractory idiopathic thrombocytopenic purpura
C Schiavotto, M Ruggeri, G Castaman, et al.
Haematologica
|
November 1, 1993
The clinical significance of the antiplatelet antibody test based on results for 265 thrombocytopenic patients
A Tosetto, M Ruggeri, C Schiavotto, et al.
Haematologica
|
May 1, 1997
Gestational thrombocytopenia: a prospective study
M Ruggeri, C Schiavotto, G Castaman, et al.
Haematologica
|
May 1, 1992
Fulminant sepsis in adults splenectomized for idiopathic thrombocytopenic purpura
F Rodeghiero, M Frezzato, C Schiavotto, et al.
Haematologica
|
May 1, 1992
A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins
F Rodeghiero, C Schiavotto, G Castaman, et al.
Haematologica
|
January 4, 1998
Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies
G Castaman, E D Bona, C Schiavotto, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Haematologica
|
November 1, 1993
Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases
C Schiavotto, F Rodeghiero
Haematologica
|
November 1, 1993
Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature
C Schiavotto, M Ruggeri, F Rodeghiero
Haematologica
|
November 1, 1993
Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol
C Schiavotto, G Castaman, F Rodeghiero
Annals of Hematology
|
February 1, 1995
Failure of repeated courses of high-dose intravenous immunoglobulin to induce stable remission in patients with chronic idiopathic thrombocytopenic purpura
C Schiavotto, M Ruggeri, F Rodeghiero
British Journal of Haematology
|
May 1, 1996
High-dose dexamethasone in adult refractory idiopathic thrombocytopenic purpura
C Schiavotto, M Ruggeri, G Castaman, et al.
Haematologica
|
November 1, 1993
The clinical significance of the antiplatelet antibody test based on results for 265 thrombocytopenic patients
A Tosetto, M Ruggeri, C Schiavotto, et al.
Haematologica
|
May 1, 1997
Gestational thrombocytopenia: a prospective study
M Ruggeri, C Schiavotto, G Castaman, et al.
Haematologica
|
May 1, 1992
Fulminant sepsis in adults splenectomized for idiopathic thrombocytopenic purpura
F Rodeghiero, M Frezzato, C Schiavotto, et al.
Haematologica
|
May 1, 1992
A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins
F Rodeghiero, C Schiavotto, G Castaman, et al.
Haematologica
|
January 4, 1998
Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies
G Castaman, E D Bona, C Schiavotto, et al.
Page
of 1